Zentalis Pharmaceuticals, Inc. (ZNTL) Free cash flow 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$125.2MFY2025 · since FY2019: -$39.5M → -$125.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$125.2M | +26.8% |
| FY2024 | -$171.1M | +17.9% |
| FY2023 | -$208.4M | -25.3% |
| FY2022 | -$166.3M | -3.8% |
| FY2021 | -$160.2M | -82.9% |
| FY2020 | -$87.6M | -121.8% |
| FY2019 | -$39.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZNTL financial trends
ZNTL RevenueZNTL Net incomeZNTL Net marginZNTL Gross profitZNTL Gross marginZNTL Operating incomeZNTL Operating marginZNTL Operating cash flowZNTL Capital expendituresZNTL Return on equityZNTL Stock buybacksZNTL Dividends paidZNTL Total assetsZNTL Total liabilitiesZNTL Shareholders’ equityZNTL overview →